Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15885
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bio-Rad Laboratories Inc (BIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. The company offers its products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Pacific Rim, among others. Bio-Rad is headquartered in Hercules, California, the US.

Bio-Rad Laboratories Inc Key Recent Developments

Apr 02,2019 Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
Feb 28,2019 Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
Feb 14,2019 2/15/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Feb 14,2019 2/21/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response: Bio-Rad Laboratories Inc.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bio-Rad Laboratories Inc – Key Facts
Bio-Rad Laboratories Inc – Key Employees
Bio-Rad Laboratories Inc – Key Employee Biographies
Bio-Rad Laboratories Inc – Major Products and Services
Bio-Rad Laboratories Inc – History
Bio-Rad Laboratories Inc – Company Statement
Bio-Rad Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bio-Rad Laboratories Inc – Business Description
Business Segment: Clinical Diagnostics
Overview
Performance
Key Stats
Business Segment: Life Science
Overview
Performance
Key Stats
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: Pacific Rim
Performance
Geographical Segment: United States
Performance
Bio-Rad Laboratories Inc – Corporate Strategy
Bio-Rad Laboratories Inc – SWOT Analysis
SWOT Analysis – Overview
Bio-Rad Laboratories Inc – Strengths
Bio-Rad Laboratories Inc – Weaknesses
Bio-Rad Laboratories Inc – Opportunities
Bio-Rad Laboratories Inc – Threats
Bio-Rad Laboratories Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
Feb 14, 2019: 2/15/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Feb 14, 2019: 2/21/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response: Bio-Rad Laboratories Inc.
Feb 01, 2019: Bio-Rad showcases new automation features of its ZE5 cell analyzer at SLAS 2019
Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories
Dec 03, 2018: Research highlights ability of Bio-Rad’s ddPCR in quantifying minimal residual disease
Dec 03, 2018: Bio-Rad quality controls now available for multiple Abbott clinical diagnostics platforms
Nov 14, 2018: Bio-Rad and the University of Chicago win patent infringement case against 10X Genomics related to droplet microfluidics technologies
Nov 01, 2018: Bio-Rad reports third-quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bio-Rad Laboratories Inc, Key Facts
Bio-Rad Laboratories Inc, Key Employees
Bio-Rad Laboratories Inc, Key Employee Biographies
Bio-Rad Laboratories Inc, Major Products and Services
Bio-Rad Laboratories Inc, History
Bio-Rad Laboratories Inc, Subsidiaries
Bio-Rad Laboratories Inc, Key Competitors
Bio-Rad Laboratories Inc, Ratios based on current share price
Bio-Rad Laboratories Inc, Annual Ratios
Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
Bio-Rad Laboratories Inc, Interim Ratios
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bio-Rad Laboratories Inc, Performance Chart (2014 - 2018)
Bio-Rad Laboratories Inc, Ratio Charts
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Covea Mutual Insurance Group Company:企業の戦略・SWOT・財務情報
    Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report Summary Covea Mutual Insurance Group Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • SEC Carbon Limited (5304):企業財務及び戦略的SWOT分析
    Summary SEC Carbon Limited (SEC Carbon) is an industrial equipment company that offers graphite products. The company's products include electrodes for aluminum smelting such as SK-Block, graphite electrodes, fine powder, batteries, paint, and others. It offers artificial graphite powder, natural gr …
  • The International Petroleum Investment Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The International Petroleum Inv …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Goodrich Petroleum Corporation (GDPMQ):企業のM&A・提携動向(石油・ガス分野)
    Summary Goodrich Petroleum Corporation (Goodrich Petroleum) is an oil and gas company that offers exploration and production services. The company explores, develops and produces oil and natural gas in Tuscaloosa Marine Shale in Eastern Louisiana and Southwestern Mississippi. It has assets in Eagle …
  • ClearFlow Inc-医療機器分野:企業M&A・提携分析
    Summary ClearFlow Inc (ClearFlow) is a medical device company that offers surgical equipment. The company designs, develops, manufactures and markets anti-clogging platform of surgical devices. Its products include gastrointestinal catheters, urinary catheters and wound drainage. ClearFlow’s product …
  • blinkx plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' blinkx plc Mergers and Acquisit …
  • Innergex Renewable Energy Inc:発電所・企業SWOT分析
    Innergex Renewable Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • WhanIn Pharmaceutical Co., Ltd. (016580):企業概要、財務及び戦略的SWOT分析
    Summary WhanIn Pharmaceutical Co., Ltd. (WhanIn Pharma) is a specialty pharmaceutical company. It undertakes the development, manufacturing, marketing, and selling of therapeutic products. The company’s product portfolio includes a wide range of antiasthmatics, antidepressants, anxiolytics and hypno …
  • LOT Polish Airlines S.A.(旅行・観光分野):企業概要及びSWOT分析
    Product Synopsis Canadean's "LOT Polish Airlines S.A.: Travel and Tourism - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • OJSC LSR Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OJSC LSR Group Mergers and Acqu …
  • Avantis Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company provides products such as single camera colonoscopy devices and third eye panoramic devices. Its third eye panoramic devices provide two side-viewing cameras supplement …
  • Deutsche Rohstoff AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Deutsche Rohstoff AG Mergers an …
  • Berry Global Group, Inc.:企業の戦略・SWOT・財務情報
    Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dai-Ichi Kogyo Seiyaku Co., Ltd. (4461):企業財務及び戦略的SWOT分析
    Summary Dai-Ichi Kogyo Seiyaku Co., Ltd. (DKS) is a chemical company that manufactures and markets surfactants and other fine chemical products. The company offers electric materials, food and life materials, surfactants, urethane materials, and functional material products. It provides surfactants …
  • Chroma Ate Inc. (2360):企業財務及び戦略的SWOT分析
    Summary Chroma Ate Inc. (Chroma) is an information technology company that offers test and measurement instruments and systems. The company offers power electronics test solution, LED and lighting and driver test solution, electric vehicle test solution, ATS, battery test system, dc power supply, AC …
  • Lincoln Electric Holdings, Inc.:戦略・SWOT・企業財務分析
    Lincoln Electric Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lincoln Electric Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Providence Service Corporation:戦略・SWOT・企業財務分析
    Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Comp Safe Support SA (CMP):企業概要、財務及び戦略的SWOT分析
    Summary Comp Safe Support SA (Comp SA) is an information technology company. The company offers IT security and network security solutions and services. Its solutions and services include special security, corporate and network security, system solutions, retail technology, IT services and education …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆